Quarterly Results

  • Company Name :
Bliss GVS Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 506197
  • NSE Symbol:
  • BLISSGVS
  • P/E(TTM):
  • 24.74
  • ISIN Demat:
  • INE416D01022
  • Div & Yield%:
  • 0.27
  • EPS(TTM):
  • 7.41
  • Book Value(₹):
  • 104.33
  • Market Cap(₹Cr.):
  • 1,939.11
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2025 ( Cr)June 2025 ( Cr)March 2025 ( Cr)
Gross Sales 190.23 163.36 156.00
Excise Duty 0.00 0.00 0.00
Net Sales 190.23 163.36 156.00
Other Operating Income 0.00 0.00 0.00
Other Income 25.84 10.59 9.36
Total Income 216.07 173.96 165.36
Total Expenditure 172.21 130.60 142.27
PBIDT 43.86 43.36 23.09
Interest 2.71 5.11 1.30
PBDT 41.15 38.25 21.79
Depreciation 7.69 7.68 7.43
Tax 11.41 12.55 3.95
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -2.75 -3.04 -1.04
Reported Profit After Tax 24.79 21.05 11.45
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 24.79 21.05 11.45
EPS (Unit Curr.) 2.35 2.00 1.08
EPS (Adj) (Unit Curr.) 2.35 2.00 1.08
Calculated EPS (Unit Curr.) 2.35 2.00 1.09
Calculated EPS (Adj) (Unit Curr.) 2.35 2.00 1.09
Calculated EPS (Ann.) (Unit Curr.) 9.39 7.98 4.35
Calculated EPS (Adj) (Ann.) (Unit Curr.) 9.39 7.98 4.35
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.56 10.55 10.54
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 23.06 26.54 14.80
PBDTM(%) 21.63 23.41 13.97
PATM(%) 13.03 12.89 7.34